| Serial Number | 88599810 |
| Word Mark | FYARRO |
| Filing Date | Friday, August 30, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 23, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 28, 2020 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, and acute respiratory disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in in pediatric, geriatric, emergency, family, and psychiatry; pharmaceutical preparations for the treatment of infectious and hereditary diseases |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AADi Bioscience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Pacific Palisades, CA 90272 |
| Party Name | AADi Bioscience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pacific Palisades, CA 90272 |
| Event Date | Event Description |
| Monday, October 23, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 23, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, March 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 21, 2023 | SOU EXTENSION 5 GRANTED |
| Friday, March 17, 2023 | SOU EXTENSION 5 FILED |
| Friday, March 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 21, 2022 | SOU EXTENSION 4 GRANTED |
| Wednesday, September 21, 2022 | SOU EXTENSION 4 FILED |
| Wednesday, September 21, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, May 7, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 7, 2022 | CORRECTED NOA E-MAILED |
| Friday, May 6, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, March 22, 2022 | SOU EXTENSION 3 FILED |
| Friday, May 6, 2022 | DIVISIONAL PROCESSING COMPLETE |
| Monday, March 21, 2022 | DIVISIONAL REQUEST RECEIVED |
| Monday, April 11, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 5, 2022 | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
| Friday, April 1, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, March 21, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, March 21, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 22, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 20, 2021 | SOU EXTENSION 2 GRANTED |
| Monday, September 20, 2021 | SOU EXTENSION 2 FILED |
| Monday, September 20, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 25, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 23, 2021 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 23, 2021 | SOU EXTENSION 1 FILED |
| Tuesday, February 23, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 22, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 28, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 24, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 24, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 24, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 16, 2020 | ASSIGNED TO LIE |
| Monday, June 8, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 11, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 11, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 11, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 4, 2019 | ASSIGNED TO EXAMINER |
| Thursday, September 12, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 3, 2019 | NEW APPLICATION ENTERED |